NASDAQ:PAHC

Phibro Animal Health Stock Forecast, Price & News

$24.77
+0.46 (+1.89 %)
(As of 07/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$24.16
$24.90
50-Day Range
$24.31
$30.08
52-Week Range
$16.27
$31.00
Volume105,406 shs
Average Volume136,148 shs
Market Capitalization$1.00 billion
P/E Ratio23.37
Dividend Yield1.97%
Beta0.53
30 days | 90 days | 365 days | Advanced Chart
Receive PAHC News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.


Phibro Animal Health logo

About Phibro Animal Health

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It also operates in Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.62 out of 5 stars

Medical Sector

861st out of 4,434 stocks

Pharmaceutical Preparations Industry

409th out of 1,734 stocks

Analyst Opinion: 0.5Community Rank: 2.2Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Phibro Animal Health (NASDAQ:PAHC) Frequently Asked Questions

Is Phibro Animal Health a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last twelve months. There are currently 2 sell ratings for the stock. The consensus among Wall Street analysts is that investors should "sell" Phibro Animal Health stock.
View analyst ratings for Phibro Animal Health
or view top-rated stocks.

What stocks does MarketBeat like better than Phibro Animal Health?

Wall Street analysts have given Phibro Animal Health a "Sell" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Phibro Animal Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Phibro Animal Health's next earnings date?

Phibro Animal Health is scheduled to release its next quarterly earnings announcement on Wednesday, August 25th 2021.
View our earnings forecast for Phibro Animal Health
.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Co. (NASDAQ:PAHC) released its quarterly earnings data on Thursday, May, 6th. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.31 by $0.03. The business earned $211.70 million during the quarter. Phibro Animal Health had a trailing twelve-month return on equity of 22.19% and a net margin of 5.37%.
View Phibro Animal Health's earnings history
.

How has Phibro Animal Health's stock been impacted by COVID-19?

Phibro Animal Health's stock was trading at $24.58 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PAHC stock has increased by 0.8% and is now trading at $24.77.
View which stocks have been most impacted by COVID-19
.

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health declared a quarterly dividend on Monday, May 3rd. Shareholders of record on Wednesday, June 2nd will be given a dividend of $0.12 per share on Wednesday, June 23rd. This represents a $0.48 annualized dividend and a yield of 1.94%. The ex-dividend date is Tuesday, June 1st.
View Phibro Animal Health's dividend history
.

Is Phibro Animal Health a good dividend stock?

Phibro Animal Health pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.97%. Phibro Animal Health does not yet have a strong track record of dividend growth. The dividend payout ratio of Phibro Animal Health is 44.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Phibro Animal Health will have a dividend payout ratio of 37.80% next year. This indicates that Phibro Animal Health will be able to sustain or increase its dividend.
View Phibro Animal Health's dividend history.

What guidance has Phibro Animal Health issued on next quarter's earnings?

Phibro Animal Health issued an update on its FY 2021 earnings guidance on Thursday, May, 27th. The company provided earnings per share guidance of 1.250-1.270 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.210. The company issued revenue guidance of $826.10 million-$830.10 million, compared to the consensus revenue estimate of $805.88 million.

What price target have analysts set for PAHC?

2 equities research analysts have issued 1-year target prices for Phibro Animal Health's stock. Their forecasts range from $22.00 to $23.00. On average, they expect Phibro Animal Health's share price to reach $22.50 in the next year. This suggests that the stock has a possible downside of 9.2%.
View analysts' price targets for Phibro Animal Health
or view top-rated stocks among Wall Street analysts.

Who are Phibro Animal Health's key executives?

Phibro Animal Health's management team includes the following people:
  • Mr. Jack Clifford Bendheim, Chairman, Pres & CEO (Age 74, Pay $2.41M)
  • Mr. Larry L. Miller, Chief Operating Officer (Age 57, Pay $756.85k)
  • Mr. Daniel M. Bendheim, Exec. VP of Corp. Strategy & Director (Age 49, Pay $537.73k)
  • Mr. Rob Aukerman, Pres of North America Region (Age 63, Pay $605.88k)
  • Mr. Damian Finio, Chief Financial Officer (Age 51)
  • Mr. Thomas G. Dagger, Sr. VP, Gen. Counsel & Corp. Sec. (Age 63)
  • Ms. Lisa A. Escudero, Sr. VP of HR (Age 59)
  • Mr. Dean J. Warras, Sr. VP of Strategic Alliances (Age 52)
  • Mr. Jonathan Bendheim, Pres of MACIE Region, GM of Israel Operations & Director (Age 45)
  • Mr. George Moffett, Managing Director of Ferro Metal & Chemical Corp. Ltd

What is Jack Bendheim's approval rating as Phibro Animal Health's CEO?

4 employees have rated Phibro Animal Health CEO Jack Bendheim on Glassdoor.com. Jack Bendheim has an approval rating of 100% among Phibro Animal Health's employees. This puts Jack Bendheim in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Phibro Animal Health's key competitors?

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT), VIVUS (VVUS), Zoetis (ZTS), Banco Bradesco (BBD) and Booking (BKNG).

What is Phibro Animal Health's stock symbol?

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include Confluence Investment Management LLC (0.52%), North Star Investment Management Corp. (0.14%) and Cardinal Capital Management (0.14%). Company insiders that own Phibro Animal Health stock include E Thomas Corcoran and Larry Lee Miller.
View institutional ownership trends for Phibro Animal Health
.

Which institutional investors are buying Phibro Animal Health stock?

PAHC stock was bought by a variety of institutional investors in the last quarter, including Cardinal Capital Management, Confluence Investment Management LLC, and North Star Investment Management Corp..
View insider buying and selling activity for Phibro Animal Health
or or view top insider-buying stocks.

How do I buy shares of Phibro Animal Health?

Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Phibro Animal Health's stock price today?

One share of PAHC stock can currently be purchased for approximately $24.77.

How much money does Phibro Animal Health make?

Phibro Animal Health has a market capitalization of $1.00 billion and generates $800.40 million in revenue each year. The company earns $33.55 million in net income (profit) each year or $1.08 on an earnings per share basis.

How many employees does Phibro Animal Health have?

Phibro Animal Health employs 2,500 workers across the globe.

What is Phibro Animal Health's official website?

The official website for Phibro Animal Health is www.pahc.com.

Where are Phibro Animal Health's headquarters?

Phibro Animal Health is headquartered at GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666.

How can I contact Phibro Animal Health?

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]


This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.